Low-risk prostate cancer patient: active treatment.
Publication
, Journal Article
Moul, JW; Saad, F
Published in: Can J Urol
June 2005
We currently lack a prospective, randomized, multicenter trial, to reassure low-risk prostate cancer patients, especially younger ones, that watchful waiting is a legitimate treatment. To better manage these patients, we need to: first, confirm that the patient has low-risk prostate cancer; second, adapt the treatment to the risk (i.e., if therapy is chosen over watchful waiting, it should be monotherapy not multiple therapy); third, be aware of age migration; fourth, know that radical prostatectomy and radiation were shown to be very effective for these patients at 10-year follow-up; and lastly, make an effort to better define watchful waiting and embrace it more, to avoid overtreatment.
Duke Scholars
Published In
Can J Urol
ISSN
1195-9479
Publication Date
June 2005
Volume
12 Suppl 2
Start / End Page
25 / 27
Location
Canada
Related Subject Headings
- Risk Assessment
- Risk
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Patient Selection
- Middle Aged
- Male
- Humans
- Aged
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W., & Saad, F. (2005). Low-risk prostate cancer patient: active treatment. Can J Urol, 12 Suppl 2, 25–27.
Moul, Judd W., and Fred Saad. “Low-risk prostate cancer patient: active treatment.” Can J Urol 12 Suppl 2 (June 2005): 25–27.
Moul JW, Saad F. Low-risk prostate cancer patient: active treatment. Can J Urol. 2005 Jun;12 Suppl 2:25–7.
Moul, Judd W., and Fred Saad. “Low-risk prostate cancer patient: active treatment.” Can J Urol, vol. 12 Suppl 2, June 2005, pp. 25–27.
Moul JW, Saad F. Low-risk prostate cancer patient: active treatment. Can J Urol. 2005 Jun;12 Suppl 2:25–27.
Published In
Can J Urol
ISSN
1195-9479
Publication Date
June 2005
Volume
12 Suppl 2
Start / End Page
25 / 27
Location
Canada
Related Subject Headings
- Risk Assessment
- Risk
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Patient Selection
- Middle Aged
- Male
- Humans
- Aged
- 3202 Clinical sciences